Contact Us   |   Sign In   |   Join
Treatment, Vaccines and Diagnostics

October

 

NIH Makes Additional Investment in Blunt & Alexander’s Shark-Tank Style Initiative to Expand COVID-19 Testing Capacity

 

Eli Lilly's LY-CoV555 antibody shows potential as COVID-19 treatment

 

Development of rapid, point of care, immunodiagnostic test for detection of the SARS-CoV-2 (COVID-19)

 

September

 

GRAM partners with Johnson & Johnson on vaccine production

 

Late-Stage Study of First Single-Shot Vaccine Begins in US

 

Johnson & Johnson’s Single-Shot COVID-19 Vaccine Moves to Final Trial Stage

 

Moderna Sees 20 Million Doses of COVID-19 Vaccine Candidate by Year End


Lilly partners with Amgen to manufacture Covid-19 antibody therapies

 

Takeda-led COVID-19 plasma product to begin trial this month

 

Galera Therapeutics Announces Dosing of First Patient in a Randomized, Double-Blind Pilot Phase 2 Clinical Trial of GC4419 for COVID-19

 

Pfizer says enrolled more than 29,000 people in its COVID-19 vaccine trial

 

Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial

 

Merck starts recruitment for COVID-19 vaccine human trial

 

Drugmakers Sanofi and GSK launch human trials for COVID-19 vaccine

 

Global trial to test whether MMR vaccine protects front-line health-care workers against COVID-19

 

BioNexus KC Awarded Grant to Improve COVID-19 Outcomes for Patients with Underlying Health Conditions

 

August

 

Physiological and biological heterogeneity in COVID-19-associated acute respiratory distress syndrome

 

Exclusive: Sanofi more confident about its coronavirus vaccines

 

Washington University develops COVID-19 saliva test

 

Translate Bio, Sanofi COVID-19 vaccine candidate produces immune response in animal studies

 

Pfizer and BioNTech share positive early data on lead mRNA vaccine candidate against COVID-19

 

Nasal vaccine against COVID-19 prevents infection in mice

 

Genome Sequences Could Be Key to COVID-19

 

COVID-19 Vaccine Trials to be Conducted at Saint Louis University, Washington University

 

Johnson & Johnson to test coronavirus vaccine in 60,000 volunteers

 

Experimental COVID-19 vaccine prevents severe disease in mice

 

Clinical trial focuses on reducing overactive immune response in COVID-19

 

Pfizer to produce COVID-19 drug at Kansas plant

 

SAB begins phase I trial of COVID-19 treatment

 

US signs Covid-19 vaccine deal with Johnson & Johnson for $1 billion

 

Merck Bets On a One-Shot Vaccine in Race With Its Faster Rivals

 

I-SPY COVID trial enrolls first patients to test various therapeutics

 

Washington University, St. Louis County collaborate on COVID-19 survey

 

AdvaMed Unveils National Testing Registry to Aid in Fight Against COVID-19, Releases First Data Set

 

Boosting immune system a potential treatment strategy for COVID-19

 

JULY

FDA Nears Decision Authorizing Covid-19 Treatment With Convalescent Plasma

 

At White House Roundtable, Paul Perreault Urges People to Donate Plasma in the Fight Against COVID-19

 

Johnson & Johnson COVID-19 vaccine provided protection in monkeys

 

Two coronavirus vaccines begin the last phase of testing: 30,000-person trials

 

MRIGlobal works with animal vaccine company on human Covid-19 vaccine


Wash U, SLU will begin Covid-19 vaccine trials

Moderna gets further $472 million U.S. award for coronavirus vaccine development

 

U.S. to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine

 

Lab-made virus mimics COVID-19 virus

 

Pfizer and BioNTech receive FDA Fast Track designation for investigational COVID-19 vaccine candidates

 

Pfizer, BioNTech's COVID-19 vaccine expected to be ready for approval by year end: WSJ

 

Coronavirus vaccine progress: Moderna partners for manufacturing deal, more trials to start soon

 

KC-tested experimental Covid-19 vaccine moving to Warp Speed after positive study results

 

Researchers Look Far, Wide for 120K Vaccine Subjects


Johnson & Johnson Prepares For COVID-19 Vaccine Human Trials

 

MRIGlobal Awarded Grant To Fund COVID-19 Laboratory Training On The African Continent


Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2

 

Effort to screen potential COVID-19 antiviral drugs underway

 

UMKC Receives First Federal Research Support to Directly Combat COVID-19

 

JUne

Covid-19 vaccine | Oxford vaccine most advanced, says WHO; Sanofi accelerates trials

 

Coronavirus vaccine candidates to begin final round of testing this summer

 

St. Louis biotech firm reaches key milestone with Covid-19 treatment


Sanofi Eyes Approval of COVID-19 Vaccine by First Half of 2021

 

Sanofi expands US vaccine venture in COVID-19 race

 

Gilead to start trial of inhaled version of Covid-fighting remdesivir

 

Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines

 

COVID-19 antibody tests evaluated as diagnostic test in low-resource settings

 

PeptiDream and Merck partner to develop Covid-19 therapeutics

 

Eli Lilly's CSO Thinks COVID-19 Antibody Treatment Could Be Ready by Fall 2020

 

Human trials for Johnson & Johnson coronavirus vaccine to start earlier than expected

 

COVID-19 mouse model will speed search for drugs, vaccines

 

Patients with COVID-19 donate specimens to advance research efforts

 

White House Works With Seven Drugmakers in ‘Warp Speed’ Push

 

MAY

Potential Covid Vaccine Speeds Growth at Catalent

 

SAB Biotherapeutics Confirms Neutralizing Antibodies to SARS-CoV-2 and Begins Clinical Manufacturing of Novel

COVID-19 Therapeutic Candidate

 

Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801

 

AVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2

 

Merck to Apply its Industry-Leading Vaccine Development Capabilities to SARS-CoV-2 Vaccine Program Originated by

Themis and Institut Pasteur

 

Merck to Announce Multiple Scientific Efforts to Combat COVID-19

 

Contract for Covid-19 testing component will bring expansion, 300 jobs to Lenexa

 

COVID-19 study looks at genetics of healthy people who develop severe illness

 

MU researcher identifies four possible treatments for COVID-19

 

Global study to test malaria drug to protect health workers from COVID-19


Takeda, CSL-led alliance and NIH to test COVID-19 plasma treatment this summer

 

MRIGlobal To Deliver Three Mobile Medical Labs For Department Of Defense

 

Pfizer producing new Covid-19 vaccine for clinical trials at St. Louis County facility

 

Pfizer and BioNTECH dose first participants in the U.S. as part of global COVID-19 mRNA vaccine development program

 

Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy

 

US allows use of 1st drug shown to help virus recovery

 

April

 

We need more covid-19 tests. We propose a ‘shark tank’ to get us there.

 

FDA allows Novartis to test hydroxychloroquine against COVID-19

 

NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines

 

The race for antibodies

 

Pfizer Advances Battle Against COVID-19 on Multiple Fronts

 

Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

 

Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19

 

Johnson & Johnson and Award-Winning Journalist Lisa Ling Explore What It Takes to End a Pandemic

 

Possible COVID-19 treatment: transfusion of antibodies from recovered patients’ blood

 

Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy

 

Area biotech works on treatment for lungs of COVID-19 patients

 

J&J picks top coronavirus vaccine candidate; human tests to start in September

 

Wash U gets FDA clearance to test a century-old idea on critical COVID-19 patients

 

Meet the SLU department on the frontlines of coronavirus vaccine development

Association Management Software Powered by YourMembership  ::  Legal